120 related articles for article (PubMed ID: 6677788)
21. Radical TUR and chemotherapy aiming at bladder preservation.
Hall RR; Roberts JT; Marsh MM
Prog Clin Biol Res; 1990; 353():163-8. PubMed ID: 2217414
[No Abstract] [Full Text] [Related]
22. 15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment.
Krause FS; Walter B; Ott OJ; Häberle L; Weiss C; Rödel C; Wullich B; Sauer R
Anticancer Res; 2011 Mar; 31(3):985-90. PubMed ID: 21498726
[TBL] [Abstract][Full Text] [Related]
23. Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer.
Iida K; Naiki T; Kawai N; Etani T; Ando R; Ikegami Y; Okamura T; Kubota H; Okada A; Kohri K; Yasui T
BMC Urol; 2016 Feb; 16():8. PubMed ID: 26920373
[TBL] [Abstract][Full Text] [Related]
24. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
[TBL] [Abstract][Full Text] [Related]
25. Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer.
Akçetin Z; Todorov J; Tüzel E; Engehausen DG; Krause FS; Sauer R; Schrott KM; Rödel C
Anticancer Res; 2005; 25(3A):1623-8. PubMed ID: 16033071
[TBL] [Abstract][Full Text] [Related]
26. [Bladder preservation by chemoradiotherapy in combination with radical TUR-Bt in muscle invasive bladder cancer].
Ishioka J; Kageyama Y; Ichiyanagi N; Saito Y; Nozu S; Nishida K; Fukuda H; Higashi Y
Nihon Hinyokika Gakkai Zasshi; 2007 Sep; 98(6):752-6. PubMed ID: 17929456
[TBL] [Abstract][Full Text] [Related]
27. Repeated transurethral resection and intravesical BCG for extensive superficial bladder tumors.
Ozen H; Ekici S; Uygur MC; Akbal C; Sahin A
J Endourol; 2001 Oct; 15(8):863-7. PubMed ID: 11724131
[TBL] [Abstract][Full Text] [Related]
28. Defining the clinical target volume for bladder cancer radiotherapy treatment planning.
Jenkins P; Anjarwalla S; Gilbert H; Kinder R
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1379-84. PubMed ID: 19394154
[TBL] [Abstract][Full Text] [Related]
29. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
Herr HW
J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
[TBL] [Abstract][Full Text] [Related]
30. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
[TBL] [Abstract][Full Text] [Related]
31. T3 bladder cancer: salvage rather than elective cystectomy after radiotherapy.
Hope-Stone HF; Oliver RT; England HR; Blandy JP
Urology; 1984 Oct; 24(4):315-20. PubMed ID: 6435300
[TBL] [Abstract][Full Text] [Related]
32. Management dilemmas in bladder cancer: radical TUR +/- systemic chemotherapy in the treatment of muscle-invasive bladder cancer.
Feneley MR; Mellon JK
Semin Urol Oncol; 2000 Nov; 18(4):300-7. PubMed ID: 11101094
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and therapy of advanced bladder carcinoma].
Bandhauer K
Helv Chir Acta; 1973 Sep; 40(4):421-6. PubMed ID: 4201823
[No Abstract] [Full Text] [Related]
34. Combined radiotherapy, chemotherapy and surgery in the management of invasive bladder cancer.
Jakse G; Frommhold H
Prog Clin Biol Res; 1988; 269():591-600. PubMed ID: 3393556
[No Abstract] [Full Text] [Related]
35. [Organ-preserving therapy in invasive bladder carcinoma].
Dunst J; Bornhof C; Altendorf-Hofmann A; Wittekind C; Schrott KM; Sauer R
Dtsch Med Wochenschr; 1992 Nov; 117(47):1783-8. PubMed ID: 1425303
[TBL] [Abstract][Full Text] [Related]
36. [Conservative treatment of bladder epitheliomas by partial cystectomy and iridium-192 curietherapy].
Mazeron JJ; Abbou CC; Chopin D; Antiphon P; Kouri G; Lansiaux P; Pierquin B; Auvert J
Ann Urol (Paris); 1987; 21(3):175-8. PubMed ID: 3116912
[TBL] [Abstract][Full Text] [Related]
37. Combined radiosurgical treatment of bladder carcinoma: preliminary results of a prospective trial.
Salvi G; Balducci M; Cellini N; D'Andrea P; De Santis M; Valentini V; Romanini A
Rays; 1985; 10(3):133-9. PubMed ID: 3843662
[No Abstract] [Full Text] [Related]
38. [Intra-operative radiotherapy with excision of urinary bladder carcinoma].
Tari K; Satake I; Kogima S; Tsugii T; Sakura M
Gan No Rinsho; 1987 Nov; 33(14):1805-9. PubMed ID: 3694809
[TBL] [Abstract][Full Text] [Related]
39. Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil.
Rödel C; Grabenbauer GG; Kühn R; Zörcher T; Papadopoulos T; Dunst J; Schrott KM; Sauer R
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1303-9. PubMed ID: 11955743
[TBL] [Abstract][Full Text] [Related]
40. Randomized trial of cystectomy with or without preoperative radiotherapy for carcinoma of the bilharzial bladder.
Ghoneim MA; Ashamallah AK; Awaad HK; Whitmore WF
J Urol; 1985 Aug; 134(2):266-8. PubMed ID: 3894693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
